Related Experiment Video
Updated: Jul 21, 2025
18:48
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.4K
JAK Inhibitors in Solid Organ Transplantation.
Sara Assadiasl1, Hanieh Mojtahedi1, Mohammad Hossein Nicknam1,2
1Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Journal of Clinical Pharmacology
|July 27, 2023
Summary
Janus kinase (JAK) inhibitors show promise in improving solid organ transplant survival by reducing rejection and inflammation. However, potential side effects like bone marrow suppression and infection require careful consideration.
Area of Science:
- Immunology
- Pharmacology
- Transplantation Medicine
Background:
- Janus kinase (JAK) inhibitors are approved for rheumatic and allergic disorders.
- Their role in solid organ transplantation (SOT) and alloimmune responses is not fully understood.
Purpose of the Study:
- To review the efficacy and safety of JAK inhibitors in SOT.
- To evaluate their impact on allograft survival and graft-versus-host disease (GvHD).
Main Methods:
- In vitro, in vivo, experimental, and clinical trial studies were summarized.
- Focus on kidney, heart, lung, and liver transplants.
- Review of JAK inhibitors in steroid-resistant GvHD post-SOT.
Main Results:
- JAK inhibitors may improve allograft function and survival.
- They can reduce acute rejection rates and scores.
- Downregulation of pro-inflammatory cytokines and oxidative stress observed.
- Adverse effects include bone marrow suppression and infection.
Conclusions:
- JAK inhibitors demonstrate a potential beneficial role in organ transplantation.
- Further research is needed to balance efficacy with safety concerns.
Related Concept Videos
01:28Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
01:26Kidney Transplant II: Surgical Procedure
36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
01:16Kidney Transplant III: Nursing Management
39
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39
01:24Tissue Transplantation
398
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
398
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
35
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
01:22Acute Kidney Injury I: Introduction
32
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
32